![]() |
Volumn 135, Issue 1, 2002, Pages 266-274
|
Pharmacological profile of the novel mammalian tachykinin, hemokinin 1
|
Author keywords
Cardiovascular effects; Hemokinin 1; Salivary secretion; Tachykinins
|
Indexed keywords
2 N (1H INDOL 3 YL CARBONYL) 1 N [N (4 TOLYLACETYL) N METHYL DEXTRO 3 (2 NAPHTHYL)ALANYL]DIAMINOCYCLOHEXANE;
HEMOKININ I;
MEN 11467;
NEPADUTANT;
NEUROKININ 1 RECEPTOR;
NEUROKININ 1 RECEPTOR ANTAGONIST;
NEUROKININ 2 RECEPTOR;
NEUROKININ 3 RECEPTOR;
NOLPITANTIUM;
OSANETANT;
PHYSALAEMIN[9 DEXTRO PROLINE SPIRO GAMMA LACTAM 10 LEUCINE 11 TRYPTOPHAN];
SAREDUTANT;
SENKTIDE;
SUBSTANCE P;
TACHYKININ;
TACHYKININ RECEPTOR AGONIST;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ANIMAL TISSUE;
ARTICLE;
BINDING AFFINITY;
BIOASSAY;
BLADDER;
BLOOD PRESSURE REGULATION;
CARDIOVASCULAR EFFECT;
CONCENTRATION RESPONSE;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFECT;
DRUG INHIBITION;
DRUG POTENCY;
DRUG RECEPTOR BINDING;
DRUG SELECTIVITY;
GUINEA PIG;
ILEUM;
IN VITRO STUDY;
IN VIVO STUDY;
LIGAND BINDING;
MALE;
NONHUMAN;
PRIORITY JOURNAL;
PULMONARY ARTERY;
RABBIT;
RAT;
SALIVATION;
|
EID: 0036157658
PISSN: 00071188
EISSN: None
Source Type: Journal
DOI: 10.1038/sj.bjp.0704443 Document Type: Article |
Times cited : (101)
|
References (32)
|